Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy.
Teriflunomide (Aubagio) approved for use by the NHS in Scotland and Northern Ireland
Synthetic Biologics Announces Issuance of U.S. Patent Adding Another Layer of Protection for the Use of Oral Estriol Candidate, Trimesta™, for Multiple Sclerosis
Brain Volume Loss during the First Year of Interferon-Beta Treatment: Baseline Inflammation and Tissue-Specific Volume Dynamics.
Efficacy and safety study of RPC1063 in relapsing multiple sclerosis patients
Antigen-specific tolerance by autologous myelin Peptide-coupled cells: a phase 1 trial in multiple sclerosis.
Ustekinumab success in refractory Crohn’s disease
Glatiramer acetate ameliorates experimental autoimmune neuritis.
Recurrent brainstem lesions mimicking infarctions in an elderly patient with neuromyelitis optica spectrum disorder.
Impact of MS during the critical window of brain development.
The Relative Importance of Baseline Pain, Fatigue, Sleep and Physical Activity: Predicting Change in Depression in Adults with Multiple Sclerosis.
Withdrawal of the marketing authorization in the European Union
Fingolimod Impedes Schwann Cell-Mediated Myelination: Implications for the Treatment of Immune Neuropathies?Effect of Fingolimod on Schwann Cells.
American Academy of Neurology Annual Meeting
Kif1b is essential for mRNA localization in oligodendrocytes and development of myelinated axons.
Glatiramer acetate in the treatment of multiple sclerosis
Altered serum content of brain-derived neurotrophic factor isoforms in multiple sclerosis.
Neuromyelitis optica and pregnancy during therapeutic B cell depletion: infant exposure to anti-AQP4 antibody and prevention of rebound relapses with low-dose rituximab postpartum.
Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system.
A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.
Risks vs benefits of glatiramer acetate: a changing perspective as new therapies emerge for multiple sclerosis.
Soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantrone.
Imovane: Best Online Pharmacy
EMD Serono
Iron content of the pulvinar nucleus of the thalamus is increased in adolescent multiple sclerosis.

Pages